RxDoctor Payments Data

Laura Starks

Nurse Practitioner · Hampton, SCNPI 1235647009

Payments from drug & device makers

$1,420in general payments, 2019–2025

Across 77 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$390
  • Novo Nordisk$229
  • Lilly USA, LLC$181
  • Abbott$140
  • AbbVie$86
  • Merck$60
  • plus $335 from 11 others

What the payments were for

  • Food & beverage$1,38898%
  • Education$322%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,420 in reported general payments places this provider in the 80th percentile of 1,346 nurse practitioner providers in South Carolina.

See all nurse practitioner providers in South Carolina

Medicare billing

Part B allowed, 2024
$69,442
Medicare patients
271
Services billed
1,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$55,944
FarxigaDapagliflozin Propanediol35$39,224
RybelsusSemaglutide33$39,164
TrulicityDulaglutide11$30,187
EliquisApixaban20$27,373
JardianceEmpagliflozin15$17,974
Breztri AerosphereBudesonide/Glycopyr/Formoterol22$13,743
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp11$2,923
Humalog Kwikpen U-100Insulin Lispro16$2,741
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$1,842
Albuterol Sulfate HfaAlbuterol Sulfate81$1,802
XulaneNorelgestromin/Ethin.Estradiol13$1,236
Gabapentin83$1,121
Atorvastatin Calcium151$1,115
Diclofenac Sodium29$1,008

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$229$95,10782 claims
AstraZenecaFarxiga, Breztri Aerosphere$390$52,96657 claims
Lilly USA, LLCTrulicity$181$30,18711 claims
PfizerEliquis$52$27,37320 claims
Boehringer IngelheimJardiance$17$17,97415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,346 nurse practitioner providers in South Carolina.

Other nurse practitioner in Hampton

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →